G Veerman Selected Research

Renal Tubular Acidosis (Distal Renal Tubular Acidosis)

10/2000

Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: a study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Veerman Research Topics

Disease

4	Neoplasms (Cancer) 01/2006 - 10/2000
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2003 - 06/2001
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2003
1	Ovarian Neoplasms (Ovarian Cancer) 06/2003
1	Melanoma (Melanoma, Malignant) 06/2003
1	Neutropenia 10/2000
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 10/2000
1	Carcinoma (Carcinomatosis) 10/2000
1	Leukopenia 10/2000

Drug/Important Bio-Agent (IBA)

3	Gemcitabine FDA Link 01/2006 - 06/2001
1	Deoxycytidine KinaseIBA 01/2006
1	Pharmaceutical PreparationsIBA 06/2003
1	Multidrug Resistance-Associated ProteinsIBA 06/2003
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2003
1	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2001
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2001
1	Fluorouracil (Carac)FDA LinkGeneric 05/2001
1	Pemetrexed (MTA)FDA Link 05/2001
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2001
1	Folic Acid AntagonistsIBA 05/2001
1	ThymidineIBA 05/2001
1	Thymidine KinaseIBA 05/2001
1	beta-D-glucosylisophosphoramide mustard (glufosfamide)IBA 10/2000
1	CreatinineIBA 10/2000
1	Alkylating AgentsIBA 10/2000
1	Glucose (Dextrose)FDA LinkGeneric 10/2000